Stefan Stevanovic
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Journal: Nature
Published: November 08, 2023
Targeting of intracellular oncoproteins with peptide-centric CARs.
Journal: Nature
Published: March 23, 2023
The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules.
Journal: EMBO reports
Published: May 23, 2022
Broad and Efficient Activation of Memory CD4+ T Cells by Novel HAdV- and HCMV-Derived Peptide Pools.
Broad and Efficient Activation of Memory CD4+ T Cells by Novel HAdV- and HCMV-Derived Peptide Pools.
Journal: Frontiers in immunology
Published: April 26, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Journal: Nature
Published: April 20, 2021
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: February 25, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.
Journal: Science translational medicine
Published: November 17, 2020
The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek's disease virus peptides by using an unprecedented binding motif.
Journal: PLoS biology
Published: November 07, 2020
Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity.
Journal: Frontiers in immunology
Published: November 05, 2020
Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.
Journal: Journal of proteome research
Published: November 03, 2020
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Journal: Nature
Published: October 19, 2020
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.
Journal: The Journal of experimental medicine
Published: August 04, 2020
Last Updated: 09/26/2026